IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Press releases
IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers
-
News
IntegraGen presents new data expanding application of miR-31 to stage III colon cancer during ESMO 2018
-
Press releases
IntegraGen Reports Financial Results for 1st Half of 2018